Gain Therapeutics (GANX) Other financing activities (2020 - 2026)
Gain Therapeutics (GANX) posted quarterly Other financing activities of $2063.0 for Q1 2026, down 99.84% quarter-over-quarter from $1.3 million in Q4 2025.
Gain Therapeutics (GANX) Other financing activities (2020 - 2026) Analysis & Trends
Gain Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $2063.0 for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $2063.0; the TTM figure through Mar 2026 stood at $1.4 million (changed N/A YoY), while the FY2025 annual figure was $1.9 million, up 1569.6% from the prior year.
- Other financing activities for Q1 2026 stood at $2063.0, down from $1.3 million in the prior quarter.
- The five-year high for Other financing activities was $1.3 million in Q4 2025, with the low at $2063.0 in Q1 2026.
- The 3-year median for Other financing activities is $56089.0 (2024), against an average of $291572.6.
- Peak annual rise in Other financing activities reached 2217.75% in 2025, while the deepest fall reached 2217.75% in 2025.
- Gain Therapeutics' Other financing activities stood at $56089.0 in 2024, then surged by 2217.75% to $1.3 million in 2025, then slumped by 99.84% to $2063.0 in 2026.
- Business Quant data shows GANX's Other financing activities at $2063.0 in Q1 2026, $1.3 million in Q4 2025, and $42000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Gain Therapeutics | 85.97 Mn | 85.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,063.00 |
| Mar 31, 2026 | 2,063.00 |
| Dec 31, 2025 | 1.30 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 42,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Dec 31, 2024 | 56,089.00 |
| Dec 31, 2024 | 56,089.00 |
| Mar 31, 2024 | 57,711.00 |
| Mar 31, 2024 | 57,711.00 |
| Dec 31, 2021 | -42.62 Mn |
| Dec 31, 2021 | -42.62 Mn |
| Mar 31, 2021 | 42.63 Mn |
| Mar 31, 2021 | 42.63 Mn |
| Dec 31, 2020 | 761.00 |
| Dec 31, 2020 | 761.00 |